Financial Instruments and Fair Value Measurements (Schedules of Concentration of Risk) (Details)		3 Months Ended			6 Months Ended	9 Months Ended
	Dec. 31, 2021	Sep. 30, 2022	Sep. 30, 2022	Sep. 24, 2021	Jun. 16, 2022	Sep. 24, 2021
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | CuraScript, Inc
Concentration Risk
Concentration Risk, Percentage				27.00%	15.60%	25.20%
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | FFF Enterprises, Inc.
Concentration Risk
Concentration Risk, Percentage		26.10%	25.70%		11.80%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Amerisource Bergen Corporation [Member]
Concentration Risk
Concentration Risk, Percentage	30.00%	30.20%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | McKesson Corporation [Member]
Concentration Risk
Concentration Risk, Percentage	15.00%	15.80%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | CuraScript, Inc
Concentration Risk
Concentration Risk, Percentage	12.70%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | FFF Enterprises, Inc.
Concentration Risk
Concentration Risk, Percentage		11.50%
Product Concentration Risk | Net Sales Attributable to Products | Acthar
Concentration Risk
Concentration Risk, Percentage		27.00%	27.80%	28.30%	25.40%	26.30%
Product Concentration Risk | Net Sales Attributable to Products | Inomax
Concentration Risk
Concentration Risk, Percentage		17.30%	17.10%	19.40%	19.00%	21.00%
Product Concentration Risk | Net Sales Attributable to Products | Therakos [Member]
Concentration Risk
Concentration Risk, Percentage		12.50%	12.40%	12.30%	12.50%	12.30%
Product Concentration Risk | Net Sales Attributable to Products | APAP
Concentration Risk
Concentration Risk, Percentage		12.40%	12.60%		11.00%